Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,000.00
-50.00 (-1.23%)
At close: Apr 17, 2025, 3:30 PM KST
-53.92%
Market Cap 33.45B
Revenue n/a
Net Income n/a
Shares Out 8.26M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,433
Average Volume 4,254
Open 4,100.00
Previous Close 4,050.00
Day's Range 4,000.00 - 4,100.00
52-Week Range 3,790.00 - 9,000.00
Beta 0.83
RSI 34.46
Earnings Date n/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

News

There is no news available yet.